Why Developing Cures for Rare Disease Isn’t So Rare Anymore

Published on :

Why Developing Cures for Rare Disease Isn’t So Rare Anymore These Six Maryland Biotech Companies Are Seeing Success in Targeting Rare Diseases September 3, 2019 Groundbreaking technology and scientific advancements, including cell and gene therapy, have fundamentally changed the way life science companies see rare disease drug development.   Life science giants like Pfizer, Merck and [….]